Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 3Prostatic Neoplasms 2Pancreatic Neoplasms 2Neoplasm Metastasis 2Erectile Dysfunction 2Carcinoma 2Urinary Incontinence 1Pyridoxine-dependent epilepsy 1Peripheral Nervous System Diseases 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neurotoxicity Syndromes 1Neoplasms 1Multiple Myeloma 1Mouth Neoplasms 1Lung Neoplasms 1Liver Neoplasms 1Head and Neck Neoplasms 1Gastric Adenocarcinoma 1Esophageal Neoplasms 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Adenocarcinoma 1

Interventions

Cisplatin 18Specimen Handling 10Radiotherapy 10Cetuximab 10Magnetic Resonance Spectroscopy 9Radiotherapy, Intensity-Modulated 8Carboplatin 71,2-diaminocyclohexaneplatinum II citrate 7pembrolizumab 6Platinum 6Paclitaxel 5Drug Therapy 5Celecoxib 5cemiplimab 4X-Rays 4Surgical Procedures, Operative 4Radiation 4Fluorouracil 4Biopsy 4Taxes 3Standard of Care 3Docetaxel 3durvalumab 2Radiotherapy, Image-Guided 2RRx-001 2Practice Guidelines as Topic 2Observation 2Nivolumab 2Injections 2Fenretinide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Mouth Neoplasms × Tadalafil × Clear all
NCT03993353 2026-02-12

Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer

University of California, San Diego

Phase 2 Completed
7 enrolled 14 charts
GastrointestinalHead & Neck

Pyridoxine-dependent epilepsy, Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Esophageal Neoplasms, Head and Neck Neoplasms, Mouth Neoplasms, Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡